These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36157930)

  • 1. Anti-tumour activity and toxicological studies of combination treatment of
    Yehya AHS; Subramaniam AV; Asif M; Kaur G; Abdul Majid AMS; Oon CE
    World J Gastroenterol; 2022 Aug; 28(32):4620-4634. PubMed ID: 36157930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymolecular botanical drug of
    Yehya AHS; Asif M; Abdul Majid AMS; Oon CE
    J Tradit Complement Med; 2023 Jan; 13(1):39-50. PubMed ID: 36685076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicological studies of
    Yehya AHS; Asif M; Kaur G; Hassan LEA; Al-Suede FSR; Abdul Majid AMS; Oon CE
    J Adv Res; 2019 Jan; 15():59-68. PubMed ID: 30581613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary effects of Orthosiphon stamineus standardized ethanolic extract and rosmarinic acid in combination with gemcitabine on pancreatic cancer.
    Yehya AHS; Asif M; Abdul Majid AMS; Oon CE
    Biomed J; 2021 Dec; 44(6):694-708. PubMed ID: 35166208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer.
    Iwanski GB; Lee DH; En-Gal S; Doan NB; Castor B; Vogt M; Toh M; Bokemeyer C; Said JW; Thoennissen NH; Koeffler HP
    Br J Pharmacol; 2010 Jun; 160(4):998-1007. PubMed ID: 20590594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Emodin combined gemcitabine inhibited the growth of pancreatic cancer in vitro and in vivo and its mechanisms study].
    Liu A; Luo J; Zhang JH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May; 32(5):652-6. PubMed ID: 22679728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
    Guo HC; Bu HQ; Luo J; Wei WT; Liu DL; Chen H; Tong HF; Wang ZH; Wu HY; Li HH; Zuo MM; Li W; Lin SZ
    Int J Oncol; 2012 Jun; 40(6):1849-57. PubMed ID: 22378302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer.
    Bao GQ; Shen BY; Pan CP; Zhang YJ; Shi MM; Peng CH
    Toxicol Lett; 2013 Sep; 222(1):23-35. PubMed ID: 23845849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
    Chen H; Wei W; Guo Y; Liu A; Tong H; Wang Z; Tan W; Liu J; Lin S
    Oncol Rep; 2011 May; 25(5):1253-61. PubMed ID: 21305255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
    Zagon IS; Jaglowski JR; Verderame MF; Smith JP; Leure-Dupree AE; McLaughlin PJ
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):510-20. PubMed ID: 15947928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
    DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
    J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.
    Damaraju VL; Bouffard DY; Wong CK; Clarke ML; Mackey JR; Leblond L; Cass CE; Grey M; Gourdeau H
    BMC Cancer; 2007 Jul; 7():121. PubMed ID: 17608948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft.
    Kotopoulis S; Delalande A; Popa M; Mamaeva V; Dimcevski G; Gilja OH; Postema M; Gjertsen BT; McCormack E
    Mol Imaging Biol; 2014 Feb; 16(1):53-62. PubMed ID: 23877869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice.
    Fujiwara Y; Shiba H; Iwase R; Haruki K; Furukawa K; Uwagawa T; Misawa T; Ohashi T; Yanaga K
    J Am Coll Surg; 2013 Feb; 216(2):320-32.e3. PubMed ID: 23219147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
    Kunnumakkara AB; Sung B; Ravindran J; Diagaradjane P; Deorukhkar A; Dey S; Koca C; Tong Z; Gelovani JG; Guha S; Krishnan S; Aggarwal BB
    Int J Cancer; 2012 Aug; 131(3):E292-303. PubMed ID: 21935918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].
    Wang SJ; Sun B; Pan SH; Chen H; Kong R; Li J; Xue DB; Bai XW; Jiang HC
    Zhonghua Wai Ke Za Zhi; 2010 Apr; 48(7):530-4. PubMed ID: 20646665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RC-3095, a gastrin-releasing peptide receptor antagonist, synergizes with gemcitabine to inhibit the growth of human pancreatic cancer CFPAC-1 in vitro and in vivo.
    Hong SK; Yang SY; Yin SH; Yang KX
    Pancreas; 2014 Jan; 43(1):15-21. PubMed ID: 24326363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A; Hu YS; Wang ZH; Tang LL; Ke PY; Lin SZ
    Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.
    Kazim S; Malafa MP; Coppola D; Husain K; Zibadi S; Kashyap T; Crochiere M; Landesman Y; Rashal T; Sullivan DM; Mahipal A
    Mol Cancer Ther; 2015 Jul; 14(7):1570-81. PubMed ID: 25934708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.